dc.description.abstract |
Background
At the end of 2022, globally, only 46% of children (aged 0–14 years) on ART had suppressed
viral loads. Viral load suppression is crucial to reduce HIV-related deaths. To suppress
the viral load at the expected level, children must be retained in ART treatment.
Nevertheless, lost to follow-up from ART treatment continues to be a global challenge, particularly,
in developing countries. Previously, primary studies were conducted in Ethiopia to
assess the incidence of lost to follow-up among HIV-positive children on ART treatment.
However, variations have been seen among the studies. Therefore, this systematic review
and meta-analysis aimed to estimate the pooled incidence of lost to follow-up among HIVpositive
children on ART and identify its associated factors in Ethiopia.
Methods
We searched PubMed, HINARI, Science Direct, Google Scholar, and African Journals
Online to obtain articles published up to November 20, 2023. Critical appraisal was done
using the Joanna Briggs Institute checklist. Heterogeneity was identified using I-square statistics.
Funnel plot and Egger’s tests were used to identify publication bias. Data was presented
using forest plots and tables. Random and fixed-effect models were used to
compute the pooled estimate.
Results
Twenty-four studies were included in the final analysis. The pooled incidence of lost to follow-
up among HIV-positive children on ART was 2.79 (95% CI: 1.99, 3.91) per 100-childyear
observations. Advanced HIV disease (HR: 2.20, 95% CI: 1.71, 2.73), having opportunistic
infection (HR: 2.59, 95% CI: 1.39; 4.78), fair or poor ART treatment adherence (HR:
2.92, 95% CI: 1.31; 6.54) and children aged between 1–5 years (HR: 2.1,95% CI: 1.44;
2.95) were factors associated with lost to follow up among HIV positive children on ART.Conclusions
The overall pooled incidence of lost to follow-up among HIV-positive children on ART is low
in Ethiopia. Therefore, counseling on ART drug adherence should be strengthened. Moreover,
emphasis has to be given to children with advanced HIV stage and opportunistic infection
to reduce the rate of lost to follow up among HIV-positive children on ART. |
en_US |